COVID-19's impact to Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Research Report 2020, Forecast to 2025
SKU ID : MMI-16402610 | Publishing Date : 09-Sep-2020 | No. of pages : 132
Detailed TOC of COVID-19's impact to Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Research Report 2020, Forecast to 2025
Table of ContentsGlobal Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Research Report 2020, Forecast to 2025
1 Market Overview
1.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Definition
1.1.1 Analysis of Macroeconomic Indicators
1.1.2 Years Considered
1.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Segment by Type
1.2.1 Lung Cancer
1.2.2 Colorectal Cancer
1.2.3 Breast Cancer
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Hospital
1.3.2 Research Institutes and Research Institutions
1.3.3 Clinic
1.3.4 Other
1.4 Overview of Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
1.4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2015-2025)
1.4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Production and Capacity (2015-2025)
1.4.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Status and Prospect (2015-2025)
1.4.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Status and Prospect (2015-2025)
1.4.5 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Status and Prospect (2014-2025)
1.4.6 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Status and Prospect (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.5.4 Porter's Five Forces Analysis
1.5.5 SWOT Analysis
1.6 Coronavirus Disease 2019 (Covid-19): Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Impact
1.6.1 How the Covid-19 is Affecting the Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry
1.6.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Business Impact Assessment - Covid-19
1.6.3 Market Trends and Epidermal Growth Factor Receptor (EGFR) Inhibitor Potential Opportunities in the COVID-19 Landscape
1.6.4 Measures / Proposal against Covid-19
2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Competition by Manufacturer
2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales and Market Share by Manufacturer (2018-2020)
2.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Market Share by Manufacturer (2018-2020)
2.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Concentration Ratio (CR5 and HHI)
2.4 Top 5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Manufacturer Market Share
2.5 Top 10 Epidermal Growth Factor Receptor (EGFR) Inhibitor Manufacturer Market Share
2.6 Date of Key Manufacturers Enter into Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
2.7 Key Manufacturers Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Offered
2.8 Mergers & Acquisitions Planning
3 Analysis of Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Key Manufacturers
3.1 Amgen Inc.
3.1.1 Company Details
3.1.2 Product Information
3.1.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.1.4 Main Business Overview
3.1.5 Amgen Inc. News
3.2 AstraZeneca Plc
3.2.1 Company Details
3.2.2 Product Information
3.2.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.2.4 Main Business Overview
3.2.5 AstraZeneca Plc News
3.3 Eli Lilly and Co.
3.3.1 Company Details
3.3.2 Product Information
3.3.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.3.4 Main Business Overview
3.3.5 Eli Lilly and Co. News
3.4 F. Hoffmann-La Roche Ltd.
3.4.1 Company Details
3.4.2 Product Information
3.4.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.4.4 Main Business Overview
3.4.5 F. Hoffmann-La Roche Ltd. News
3.5 Novartis AG
3.5.1 Company Details
3.5.2 Product Information
3.5.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.5.4 Main Business Overview
3.5.5 Novartis AG News
4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Categorized by Regions (2015-2020)
4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Region
4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Region (2015-2019)
4.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Detail
4.4.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Growth Rate (2015-2020)
4.4.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Detail
4.5.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Growth Rate (2015-2020)
4.5.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Detail
4.6.1 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Growth Rate (2015-2020)
4.6.2 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Detail
4.7.1 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Growth Rate (2015-2020)
4.7.2 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales, Revenue, Price and Gross Margin (2015-2020)
5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Segment by Type
5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Sales and Market Share by Type (2015-2020)
5.1.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales and Market Share by Type (2015-2020)
5.1.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Market Share by Type (2015-2020)
5.2 Lung Cancer Sales Growth Rate and Price
5.2.1 Global Lung Cancer Sales Growth Rate (2015-2020)
5.2.2 Global Lung Cancer Price (2015-2020)
5.3 Colorectal Cancer Sales Growth Rate and Price
5.3.1 Global Colorectal Cancer Sales Growth Rate (2015-2020)
5.3.2 Global Colorectal Cancer Price (2015-2020)
5.4 Breast Cancer Sales Growth Rate and Price
5.4.1 Global Breast Cancer Sales Growth Rate (2015-2020)
5.4.2 Global Breast Cancer Price (2015-2020)
5.5 Others Sales Growth Rate and Price
5.5.1 Global Others Sales Growth Rate (2015-2020)
5.5.2 Global Others Price (2015-2020)
6 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Segment by Application
6.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Application (2015-2020)
6.2 Hospital Sales Growth Rate (2015-2020)
6.3 Research Institutes and Research Institutions Sales Growth Rate (2015-2020)
6.4 Clinic Sales Growth Rate (2015-2020)
6.5 Other Sales Growth Rate (2015-2020)
7 Epidermal Growth Factor Receptor (EGFR) Inhibitor Related Market Analysis
7.1 Upstream Analysis
7.1.1 Macro Analysis of Upstream Markets
7.1.2 Key Players in Upstream Markets
7.1.3 Upstream Market Trend Analysis
7.1.4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Manufacturing Cost Analysis
7.2 Downstream Market Analysis
7.2.1 Macro Analysis of Down Markets
7.2.2 Key Players in Down Markets
7.2.3 Downstream Market Trend Analysis
7.2.4 Sales Channel, Distributors, Traders and Dealers
8 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Forecast
8.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales, Revenue Forecast
8.1.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Growth Rate Forecast (2020-2025)
8.1.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate Forecast (2020-2025)
8.1.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Price and Trend Forecast (2020-2025)
8.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Forecast by Region (2020-2025)
8.2.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales, Revenue Forecast (2020-2025)
8.2.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales, Revenue Forecast (2020-2025)
8.2.3 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Production, Revenue Forecast (2020-2025)
8.2.4 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Production, Revenue Forecast (2020-2025)
9 Research Findings and Conclusion
10 Appendix
List of Figures, Tables and Charts Available in COVID-19's impact to Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Research Report 2020, Forecast to 2025
List of Tables and FiguresFigure Epidermal Growth Factor Receptor (EGFR) Inhibitor Picture
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales by Type
Figure Global Sales Market Share of Epidermal Growth Factor Receptor (EGFR) Inhibitor by Product Type in 2019
Table Breakdown of Epidermal Growth Factor Receptor (EGFR) Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3)
Figure Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure Lung Cancer Picture
Figure Colorectal Cancer Picture
Figure Breast Cancer Picture
Figure Others Picture
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales by Application
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Application in 2019
Figure Hospital Picture
Figure Research Institutes and Research Institutions Picture
Figure Clinic Picture
Figure Other Picture
Table Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Comparison by Region (2019-2025) (K Units) & (Million US$)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (Million US$) (2015-2025)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Production (K Units) (2015-2025)
Figure North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (Million US$) Growth Rate (2015-2025)
Figure Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (Million US$) Growth Rate (2015-2025)
Figure Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (Million US$) Growth Rate (2014-2025)
Figure China Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (Million US$) Growth Rate (2015-2025)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table SWOT Analysis
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales by Manufacturer (2018-2020)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Manufacturer in 2019
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Manufacturer (2018-2020)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Manufacturer in 2019
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Epidermal Growth Factor Receptor (EGFR) Inhibitor Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
Table Key Manufacturers Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Type
Table Mergers & Acquisitions Planning
Table Amgen Inc. Company Profile
Figure Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Picture and Specifications of Amgen Inc.
Table Epidermal Growth Factor Receptor (EGFR) Inhibitor Production, Price, Revenue and Gross Margin of 2018-2020
Figure Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2018-2020)
Table Amgen Inc. Main Business
Table Amgen Inc. Recent Development
Table AstraZeneca Plc Company Profile
Figure Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Picture and Specifications of AstraZeneca Plc
Table Epidermal Growth Factor Receptor (EGFR) Inhibitor Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2018-2020)
Table AstraZeneca Plc Main Business
Table AstraZeneca Plc Recent Development
Table Eli Lilly and Co. Company Profile
Figure Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Picture and Specifications of Eli Lilly and Co.
Table Epidermal Growth Factor Receptor (EGFR) Inhibitor Production, Price, Revenue and Gross Margin of 2018-2020
Figure Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2018-2020)
Table Eli Lilly and Co. Main Business
Table Eli Lilly and Co. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Profile
Figure Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Picture and Specifications of F. Hoffmann-La Roche Ltd.
Table Epidermal Growth Factor Receptor (EGFR) Inhibitor Production, Price, Revenue and Gross Margin of 2018-2020
Figure F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2018-2020)
Table F. Hoffmann-La Roche Ltd. Main Business
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Novartis AG Company Profile
Figure Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Picture and Specifications of Novartis AG
Table Epidermal Growth Factor Receptor (EGFR) Inhibitor Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2018-2020)
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales (K Units) by Region (2015-2020)
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Region (2015-2019)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Region (2015-2019)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Region in 2018
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (Million US$) by Region (2015-2020)
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Region (2015-2020)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Region (2015-2020)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Region in 2019
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales (K Units) Growth Rate (2015-2020)
Figure Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales (K Units) Growth Rate (2015-2020)
Table Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales (K Units) Growth Rate (2015-2020)
Table Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales (K Units) Growth Rate (2015-2020)
Table China Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales by Type (2015-2020)
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Type (2015-2020)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Type in 2019
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Type (2015-2020)
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2015-2020)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type in 2019
Figure Global Lung Cancer Sales Growth Rate (2015-2025)
Figure Global Lung Cancer Price (2015-2020)
Figure Global Colorectal Cancer Sales Growth Rate (2015-2025)
Figure Global Colorectal Cancer Price (2015-2020)
Figure Global Breast Cancer Sales Growth Rate (2015-2025)
Figure Global Breast Cancer Price (2015-2020)
Figure Global Others Sales Growth Rate (2015-2025)
Figure Global Others Price (2015-2020)
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Application (2015-2020)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales Market Share by Application in 2019
Figure Global Hospital Sales Growth Rate (2015-2025)
Figure Global Research Institutes and Research Institutions Sales Growth Rate (2015-2025)
Figure Global Clinic Sales Growth Rate (2015-2025)
Figure Global Other Sales Growth Rate (2015-2025)
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Epidermal Growth Factor Receptor (EGFR) Inhibitor
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Price and Trend Forecast (2020-2025)
Table Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales (K Units) Forecast by Region (2020-2025)
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Production Market Share Forecast by Region (2020-2025)
Figure North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Epidermal Growth Factor Receptor (EGFR) Inhibitor Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Keyplayers in COVID-19's impact to Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Research Report 2020, Forecast to 2025
Amgen Inc.AstraZeneca Plc
Eli Lilly and Co.